In addition, the activation of WNT5a/PKC pathway could enhance the stemness of NSCLC cells and inhibit cell apoptosis and their sensitivity to chemotherapies by increasing endoplasmic reticulum release of Ca2+, PKC, and CaMKII and the subsequent activation of NF-kB signaling. This evidence concerns the gene PRRT2 and non-small cell lung carcinoma.